Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD

Gabriela Spulber1, Eini Niskanen, Stuart Macdonald

  • 1University of Eastern Finland, Kuopio Campus, Institute of Clinical Medicine/Neurology, Kuopio. gabriela.spulber@uef.fi

Current Alzheimer Research
|December 24, 2011
PubMed

Insights

Progressive mild cognitive impairment (MCI) shows accelerated grey matter loss in key brain regions up to two years before Alzheimer's disease (AD) diagnosis. Stable MCI patients did not exhibit this significant brain atrophy, highlighting differences in neurodegeneration.

Area of Science:

  • Neuroimaging
  • Neurodegeneration
  • Cognitive Neurology

Background:

  • Mild cognitive impairment (MCI) is a prodromal stage for dementia, particularly Alzheimer's disease (AD).
  • Understanding the neuroanatomical differences between progressive and stable MCI is crucial for early detection and intervention.
  • Grey matter (GM) changes precede clinical diagnosis in neurodegenerative diseases.

Purpose of the Study:

  • To characterize grey matter (GM) distribution and dynamics in progressive versus stable MCI over a two-year period before Alzheimer's disease (AD) conversion.
  • To identify specific brain regions affected by GM loss in individuals who progress from MCI to AD.

Main Methods:

  • Longitudinal voxel-based morphometry (VBM) analysis of three serial MRI scans.
  • Inclusion of 48 stable MCI and 12 progressive MCI cases.
  • Scans acquired at approximately 1-year intervals, with the final scan for the progressive group at AD diagnosis.

Main Results:

  • Cross-sectional analysis revealed lower GM volumes in the parahippocampal gyrus, precuneus, and posterior cingulate 12 months before AD diagnosis in the progressive MCI group.
  • Longitudinal VBM showed accelerated GM loss in temporal neocortex, parahippocampal cortex, and cingulate gyrus in progressive MCI.
  • Affected regions also included the frontal lobe, insula, and cerebellum in the progressive MCI group.

Conclusions:

  • Progressive MCI exhibits significant grey matter atrophy in specific cortical and subcortical regions preceding clinical Alzheimer's disease diagnosis.
  • These findings offer insights into the neurodegenerative processes underlying MCI progression to AD.
  • Further studies are needed to verify the clinical relevance of these observed neuroanatomical changes.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...